Skip to content

DRUGS MADE IN AMERICA ACQUISITION II CORP.

DMII DMIIR DMIIU

CIK 0002040475

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
$4.19M
+2,859.7% YoY Q1 May 2026
EPS Diluted (TTM)
—
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$347.72K
Q1 May 2026
Total Debt
$450K
Q1 May 2026
Shares Outstanding
63.7M sh
Q1 May 2026

Revenue & Net Income

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings